Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma

Archives of Iranian Medicine

Volumn 15, Issue 11, 2012, Pages 713-722

  Roshandel, Gholamreza ^a,b   Semnani, Shahryar ^b   Malekzadeh, Reza ^a   Dawsey, Sanford M ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; BENZ[A]ANTHRACENE; BENZO[A]PYRENE; BENZO[B]FLUORANTHENE; BENZO[K]FLUORANTHENE; DIBENZ[A,H]ANTHRACENE; FLUORANTHENE; FLUORENE; INDENO[1,2,3 CD]PYRENE; NAPHTHALENE; OPIATE; ORGANIC MATTER; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PYRENE;

BRAZIL; CANCER CONTROL; CARCINOGENESIS; CARCINOGENICITY; CASE CONTROL STUDY; CHINA; COMBUSTION; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS; FOOD CONTAMINATION; GENE MUTATION; HIGH RISK POPULATION; HUMAN; INDOOR AIR POLLUTION; IRAN; OCCUPATIONAL EXPOSURE; REVIEW; SMOKING; TUMOR SUPPRESSOR GENE;

AIR POLLUTION, INDOOR; CARCINOMA, SQUAMOUS CELL; ENVIRONMENTAL EXPOSURE; ESOPHAGEAL NEOPLASMS; FOOD; HUMANS; MUTATION; OCCUPATIONAL EXPOSURE; POLYCYCLIC HYDROCARBONS, AROMATIC; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84868223113     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Review

References (141)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globo-can 2008, cancer incidence and mortality worldwide: Iarc cancerbase no. 10. Lyon: International Agency for Research on Cancer; 2010 [03/02/2011]; Available from: URL: http://globocan.iarc.fr.
2. Das A. Tumors of the esophagus. In: Feldman M, Friedman L, Brandt LJ, eds. Sleisenger and fordtran's gastrointestinal and liver disease: Pathophysiology, diagnosis, management. 9th ed. Philadelphia: Saun-ders Elsevier; 2010. 745-770.
3. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the caspian littoral of iran: The caspian cancer registry. Br J Cancer. 1973; 28: 197-214.
4. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the turkmen plain, east-ern part of the caspian littoral of iran: A retrospective cancer surveil-lance. Cancer Detect Prev. 2006; 30: 14-19.
5. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat S, Nouraie S, et al. Cancer incidence in golestan province: Report of an ongoing population-based cancer registry in iran between 2004 and 2008. Arch Iran Med. 2012; 15: 196.
6. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, et al. Epidemiologic features of upper gastrointestinal tract cancers in northeastern iran. Br J Cancer. 2004; 90: 1402-1406.
7. Brown LM, Devesa SS, Chow W-H. Incidence of adenocarcinoma of the esophagus among white americans by sex, stage, and age. J Natl Cancer Inst. 2008; 100: 1184-1187.
8. Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the united states by race, sex, and histologic type, 1977-2005. Br J Cancer. 2009; 101: 855-859.
9. Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP Continuing rapid increase in esophageal adenocarcinoma in england and wales. Am J Gastroenterol. 2008; 103: 2694-2699.
10. Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffeta P, Malekzadeh R. Oesophageal cancer in golestan province, a high-incidence area in northern iran-a review. Eur J Cancer. 2009; 45: 3156-3165.
11. Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y, et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from linx-ian, china. Cancer. 1994; 74: 1686-1692.
12. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, et al. Histological precursors of oesophageal squamous cell carcinoma: Re-sults from a 13 year prospective follow up study in a high risk popula-tion. Gut. 2005; 54: 187-192.
13. Kamangar F, Chow W-H, C. Abnet CM, Dawsey S. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009; 38: 27-57.
14. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hol-lenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007; 165: 1424.
15. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oe-sophageal squamous cell carcinoma in a high-risk area of iran. Br J Cancer. 2008; 98: 1857-1863.
16. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern iran: Population based case-control study. Br Med J. 2009; 338: b929.
17. Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in south america. Int J Cancer. 2000; 88: 658-664.
18. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, et al. Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer. 2007; 121: 2753-2760.
19. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000; 92: 1753-1763.
20. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, et al. Prospective study of serum vitamin e levels and esophageal and gastric cancers. J Natl Cancer Inst. 2003; 95: 1414-1416.
21. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J ClinNutr. 2004; 79: 80-85.
22. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are asso-ciated with higher risk of esophageal squamous cell carcinoma. Can-cer Epidemiol Biomarkers Prev. 2008; 17: 3062-3068.
23. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal can-cer: Results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009; 38: 978-988.
24. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stan-ford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003; 95: 1404-1413.
25. Phillips DH. Polycyclic aromatic hydrocarbons in the diet. Mutat Res. 1999; 443: 139-147.
26. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V. Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol. 2005; 6: 931.
27. Harvey RG. Polycyclic aromatic hydrocarbons: Chemistry and carci-nogenicity. Cambridge: Cambridge University Press; 1991.
28. Rappaport SM, Waidyanatha S, Serdar B. Naphthalene and its bio-markers as measures of occupational exposure to polycyclic aromatic hydrocarbons. J Environ Monit. 2004; 6: 413-416.
29. Simko P. Determination of polycyclic aromatic hydrocarbons in smoked meat products and smoke flavouring food additives. J Chro-matogr B Analyt Technol BiomedLife Sci. 2002; 770: 3-18.
30. Phillips DH. Fifty years of benzo (a) pyrene. Nature. 1983; 303: 468-472.
31. Rogan EG, Devanesan PD, Ramakrishna NVS, Higginbotham S, Padmavathi NS, Chapman K, et al. Identification and quantitation of benzo [a] pyrene-DNA adducts formed in mouse skin. Chem Res Toxi-col. 1993; 6: 356-363.
32. Jongeneelen FJ, Bos RP, Anzion RB, Theuws JL, Henderson PT. Bio-logical monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine. Scand J Work Environ Health. 1986; 12: 137-143.
33. Becher G, Bjorseth A. Determination of exposure to polycyclic aro-matic hydrocarbons by analysis of human urine. Cancer Lett. 1983; 17: 301-311.
34. Clonfero E, Jongeneelen F, Zordan M, Levis AG. Biological monitor-ing of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabo-lites in urine. AC Sci Publ. 1990; 215-222.
35. Zhao ZH, Quan WY, Tian DH. Urinary 1-hydroxypyrene as an indica-tor of human exposure to ambient polycyclic aromatic hydrocarbons in a coal-burning environment. Sci Total Environ. 1990; 92: 145-154.
36. Castano-Vinyals G, D'errico A, Malats N, Kogevinas M. Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup Environ Med. 2004; 61: e12.
37. Omland O, Sherson D, Hansen AM, Sigsgaard T, Autrup H, Over-gaard E. Exposure of iron foundry workers to polycyclic aromatic hy-drocarbons: Benzo(a)pyrene-albumin adducts and 1-hydroxypyrene as biomarkers for exposure. Occup Environ Med. 1994; 51: 513-518.
38. Zhao ZH, Quan WY, Tian DH. Experiments on the effects of several factors on the 1-hydroxypyrene level in human urine as an indicator of exposure to polycyclic aromatic hydrocarbons. Sci Total Environ. 1992; 113: 197-207.
39. Kang D, Rothman N, Cho SH, Lim HS, Kwon HJ, Kim SM, et al. As-sociation of exposure to polycyclic aromatic hydrocarbons (estimated from job category) with concentration of 1-hydroxypyrene glucuro-nide in urine from workers at a steel plant. Occup Environ Med. 1995; 52: 593-599.
40. Kang DH, Rothman N, Poirier MC, Greenberg A, Hsu CH, Schwartz BS, et al. Interindividual differences in the concentration of 1-hy-droxypyrene-glucuronide in urine and polycyclic aromatic hydrocar-bon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. Carcinogenesis. 1995; 16: 1079-1085.
41. Buratti M, Campo L, Fustinoni S, Cirla PE, Martinotti I, Cavallo D, et al. Urinary hydroxylated metabolites of polycyclic aromatic hydro-carbons as biomarkers of exposure in asphalt workers. Biomarkers. 2007; 12:221-239.
42. Chetiyanukornkul T, Toriba A, Kameda T, Tang N, Hayakawa K. Simultaneous determination of urinary hydroxylated metabolites of naphthalene, fluorene, phenanthrene, fluoranthene and pyrene as mul-tiple biomarkers of exposure to polycyclic aromatic hydrocarbons. Anal Bioanal Chem. 2006; 386: 712-718.
43. Rossbach B, Preuss R, Letzel S, Drexler H, Angerer J. Biological monitoring of occupational exposure to polycyclic aromatic hydro-carbons (pah) by determination of monohydroxylated metabolites of phenanthrene and pyrene in urine. Int Arch Occup Environ Health. 2007; 81:221-229.
44. Seidel A, Spickenheuer A, Straif K, Rihs HP, Marczynski B, Scheren-berg M, et al. New biomarkers of occupational exposure to polycyclic aromatic hydrocarbons. J Toxicol Environ Health A. 2008; 71: 734-745.
45. Sobus JR, Waidyanatha S, Mcclean MD, Herrick RF, Smith TJ, Garshick E, et al. Urinary naphthalene and phenanthrene as biomark-ers of occupational exposure to polycyclic aromatic hydrocarbons. Occup Environ Med. 2009; 66: 99-104.
46. Pesch B, Kappler M, Straif K, Marczynski B, Preuss R, Rossbach B, et al. Dose-response modeling of occupational exposure to polycyclic aromatic hydrocarbons with biomarkers of exposure and effect. Can-cer Epidemiol Biomarkers Prev. 2007; 16: 1863-1873.
47. Godschalk RW, Van Schooten FJ, Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol. 2003; 36: 1-11.
48. Rothman N, Poirier M, Baser M, Hansen J, Gentile C, Bowman ED, et al. Formation of polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells during consumption of charcoal-broiled beef. Carcinogenesis. 1990; 11: 1241-1243.
49. Perera FP, Hemminki K, Young TL, Brenner D, Kelly G, Santella RM. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res. 1988; 48: 2288-2291.
50. Kriek E, Rojas M, Alexandrov K, Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: Relevance as biomarkers for exposure and cancer risk. Mutat Res. 1998; 400: 215-231.
51. Rothman N, Poirier MC, Haas RA, Correa-Villasenor A, Ford P, Han-sen JA, et al. Association of pah-DNA adducts in peripheral white blood cells with dietary exposure to polyaromatic hydrocarbons. En-viron Health Perspect. 1993; 99: 265-267.
52. Taioli E, Sram RJ, Binkova B, Kalina I, Popov TA, Garte S, et al. Bio-markers of exposure to carcinogenic pahs and their relationship with environmental factors. Mutat Res. 2007; 620: 16-21.
53. Gyorffy E, Anna L, Gyori Z, Segesdi J, Minarovits J, Soltesz I, et al. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: Correlations between tissues and detection by 32p-postlabelling and immunoassay. Carcinogenesis. 2004; 25: 1201-1209.
54. Van Gijssel HE, Schild LJ, Watt DL, Roth MJ, Wang GQ, Dawsey SM, et al. Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal bi-opsies taken in 1985. Mutat Res. 2004; 547: 55-62.
55. Toriba A, Kuramae Y, Chetiyanukornkul T, Kizu R, Makino T, Na-kazawa H, et al. Quantification of polycyclic aromatic hydrocarbons (pahs) in human hair by hplc with fluorescence detection: Abiological monitoring method to evaluate the exposure to pahs. Biomed Chro-matogr. 2003; 17: 126-132.
56. Beskid O, Binkova B, Dusek Z, Rossner P, Solansky I, Kalina I, et al. Chromosomal aberrations by fluorescence in situ hybridization (fìsh)--biomarker of exposure to carcinogenic pahs. Mutat Res. 2007; 620: 62-70.
57. Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, Abnet CC, et al. Polycyclic aromatic hydrocarbon exposure in oe-sophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern iran. Gut. 2010; 59: 1178-1183.
58. Ponder B. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-east-ern iran. Arch Iran Med. 2010; 13: 457-458.
59. Iarc. Iarc monographs on the evaluation of carcinogenic risks to hu-mans, no 92: Some non-heterocyclic polycyclic aromatic hydrocar-bons and some related exposures. Lyon: International Agency for Re-search on Cancer; 2010.
60. Pott P. Chirurgical observations. Natl Cancer InstMonogr. 1963; 10: 7.
61. Gustavsson P, Gustavsson A, Hogstedt C. Excess of cancer in swedish chimney sweeps. Br J IndMed. 1988; 45: 777-781.
62. Armstrong BG, Gibbs G. Exposure-response relationship between lung cancer and polycyclic aromatic hydrocarbons (pahs). Occup En-viron Med. 2009; 66: 740-746.
63. Petralia SA, Vena JE, Freudenheim JL, Dosemeci M, Michalek A, Goldberg MS, et al. Risk of premenopausal breast cancer in associa-tion with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health. 1999; 25: 215-221.
64. Carta P, Aru G, Cadeddu C, Gigli G, Papi G, Carta F, et al. Mortality for pancreatic cancer among aluminium smelter workers in sardinia, italy. G Ital Med Lav Ergon. 2004; 26: 83-89.
65. Nadon L, Siemiatycki J, Dewar R, Krewski D, Gerin M. Cancer risk due to occupational exposure to polycyclic aromatic hydrocarbons. Am J Ind Med. 1995; 28: 303-324.
66. Allen-Hoffmann BL, Rheinwald JG. Polycyclic aromatic hydrocar-bon mutagenesis of human epidermal keratinocytes in culture. Proc Natl Acad Sci USA. 1984; 81: 7802-7806.
67. Benbrahim-Tallaa L, Baan RA, Grosse Y, Lauby-Secretan B, El Ghis-sassi F, Bouvard V, et al. Carcinogenicity of diesel-engine and gaso-line-engine exhausts and some nitroarenes. Lancet Oncol. 2012; DOI. 10.1016/S1470-2045(12)70280-2.
68. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hain-aut P. Tobacco smoke carcinogens, DNA damage and p 53 mutations in smoking-associated cancers. Oncogene. 2002; 21: 7435-7451.
69. Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 1991; 51: 6185-6189.
70. Gao M, Li Y, Sun Y, Long J, Kong Y, Yang S, et al. A common carcino-gen benzo [a] pyrene causes p53 overexpression in mouse cervix via DNA damage. Mutat Res. 2011; 725: 69-75.
71. Denissenko MF, Pao A, Tang M-S, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science. 1996; 274: 430-432.
72. Shen YM, Troxel AB, Vedantam S, Trevor M, Field J. Comparison of p53 mutations induced by pah o-quinones with those caused by anti-benzo [a] pyrene diol epoxide in vitro: Role of reactive oxygen and biological selection. Chem Res Toxicol. 2006; 19: 1441-1450.
73. Yu D, Jesse A, Trevor M, Field J. Reactive oxygen species generated by pah o-quinones cause change-in-function mutations in p53. Chem Res Toxicol. 2002; 15: 832-842.
74. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, et al. N Engl J Med. 1995; 332: 712-717.
75. Abedi-Ardekani B, Kamangar F, Sotoudeh M, Villar S, Islami F, Aghcheli K, et al. Extremely high tp53 mutation load in esophageal squamous cell carcinoma in golestan province, iran. PLoS One. 2011; 6: e29488.
76. Cairns J, editor. Cancer and society. San Francisco: Freeman; 1978.
77. Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA. A com-parison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis. 1998; 19: 117-124.
78. Vieth M, Stolte M. [do polycyclic aromatic hydrocarbons (pah) cause squamous cell carcinoma of the esophagus?]. Z Gastroenterol. 1999; 37: 579-580.
79. Gustavsson P, Jakobsson R, Johansson H, Lewin F, Norell S, Rutkvist LE. Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: A case-control study in swe-den. Occup Environ Med. 1998; 55: 393-400.
80. Fagundes RB, Abnet CC, Strickland PT, Kamangar F, Roth MJ, Tay-lor PR, et al. Higher urine 1-hydroxy pyrene glucuronide (1-ohpg) is associated with tobacco smoke exposure and drinking mate in healthy subjects from rio grande do sul, brazil. BMC Cancer. 2006; 6: 139.
81. Ward MH, Sinha R, Heineman EF, Rothman N, Markin R, Weisen-burger DD, et al. Risk of adenocarcinoma of the stomach and esopha-gus with meat cooking method and doneness preference. Int J Cancer. 1997; 71: 14-19.
82. Roth MJ, Strickland KL, Wang GQ, Rothman N, Greenberg A, Dawsey SM. High levels of carcinogenic polycyclic aromatic hydro-carbons present within food from linxian, china may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer. 1998; 34: 757-758.
83. Roth M, Qiao YL, Rothman N, Tangrea J, Dawsey S, Wang GQ, et al. High urine 1-hydroxypyrene glucuronide concentrations in linxian, china, an area of high risk for squamous oesophageal cancer. Biomark-ers. 2001; 6: 381-386.
84. Kamangar F, Strickland PT, Pourshams A, Malekzadeh R, Boffetta P, Roth MJ, et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern iran. Anticancer Res. 2005; 25: 425-428.
85. Marjani HA, Biramijamal F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R. Investigation of nqo1 genetic polymorphism, nqo1 gene expression and pah-DNA adducts in escc. A case-control study from iran. Genet Mol Res. 2010; 9: 239-249.
86. Garte S, Taioli E, Raimondi S, Paracchini V, Binkova B, Sram RJ, et al. Effects of metabolic genotypes on intermediary biomarkers in subjects exposed to pahs: Results from the expah study. Mutat Res. 2007; 620: 7-15.
87. Santodonato J, Howard P, Basu D. Health and ecological assessment of polynuclear aromatic hydrocarbons. J Environ Pathol Toxicol. 1981; 5: 1.
88. Larsson BK. Polycyclic aromatic hydrocarbons in smoked fish. Z Leb-ensm Unters Forsch. 1982; 174: 101.
89. Dennis MJ, Massey RC, Mcweeny DJ, Knowles ME, Watson D. Analysis of polycyclic aromatic hydrocarbons in uk total diets. Food Chem Toxicol. 1983; 21: 569-574.
90. Kobayashi R, Okamoto RA, Maddalena RL, Kado NY. Polycyclic aromatic hydrocarbons in edible grain: A pilot study of agricultural crops as a human exposure pathway for environmental contaminants using wheat as a model crop. Environ Res. 2008; 107: 145-151.
91. Ignesti G, Lodovici M, Dolara P, Lucia P, Grechi D. Polycyclic aro-matic hydrocarbons in olive fruits as a measure of air pollution in the valley offlorence (italy). Bull Environ Contam Toxicol. 1992; 48: 809-814.
92. Wild SR, Berrow ML, McGrath SP, Jones KC. Polynuclear aromatic hydrocarbons in crops from long-term field experiments amended with sewage sludge. Environ Pollut. 1992; 76: 25-32.
93. Menzie CA, Potocki BB, Santodonato J. Exposure to carcinogenic pahs in the environment. Environ Sci Technol. 1992; 26: 1278-1284.
94. Vyskocil A, Fiala Z, Fialova D, Krajak V, Viau C. Environmental ex-posure to polycyclic aromatic hydrocarbons in czech republic. Hum Exp Toxicol. 1997; 16: 589-595.
95. De Vos RH, Van Dokkum W, Schouten A, De Jong-Berkhout P. Poly-cyclic aromatic hydrocarbons in dutch total diet samples (1984-1986). Food Chem Toxicol. 1990; 28: 263-268.
96. Lodovici M, Dolara P, Casalini C, Ciappellano S, Testolin G. Poly-cyclic aromatic hydrocarbon contamination in the italian diet. Food Addit Contam. 1995; 12: 703-713.
97. Falco G, Domingo JL, Llobet JM, Teixido A, Casas C, Muller L. Poly-cyclic aromatic hydrocarbons in foods: Human exposure through the diet in catalonia, spain. J Food Prot. 2003; 66: 2325-2331.
98. Mahboubi EO, Aramesh B. Epidemiology of esophageal cancer in iran, with special reference to nutritional and cultural aspects. Prev Med. 1980; 9: 613-621.
99. Hakami R, Mohtadinia J, Etemadi A, Kamangar F, Nemati M, Pour-shams A, et al. Dietary intake of benzo(a)pyrene and risk of esopha-geal cancer in north of iran. Nutr Cancer. 2008; 60: 216-221.
100. Dennis MJ, Massey RC, Cripps G, Venn I, Howarth N, Lee G. Factors affecting the polycyclic aromatic hydrocarbon content of cereals, fats and other food products. Food Addit Contam. 1991; 8: 517-530.
101. Gomaa EA, Gray JI, Rabie S, Lopez-Bote C, Booren AM. Polycy-clic aromatic hydrocarbons in smoked food products and commercial liquid smoke flavourings. Food Addit Contam. 1993; 10: 503-521.
102. Gunier RB, Reynolds P, Hurley SE, Yerabati S, Hertz A, Strickland P, et al. Estimating exposure to polycyclic aromatic hydrocarbons: A comparison of survey, biological monitoring, and geographic infor-mation system-based methods. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1376-1381.
103. Alomirah H, Al-Zenki S, Al-Hooti S, Zaghloul S, Sawaya W, Ahmed N, et al. Concentrations and dietary exposure to polycyclic aromatic hydrocarbons (pahs) from grilled and smoked foods. Food Control. 2011; 22: 2028-2035.
104. Victora CG, Munoz N, Horta BL, Ramos EO. Patterns of mate drink-ing in a brazilian city. Cancer Res. 1990; 50: 7112-7115.
105. Sewram V, De Stefani E, Brennan P, Boffetta P. Mate consumption and the risk of squamous cell esophageal cancer in uruguay. Cancer Epidemiol Biomarkers Prev. 2003; 12: 508-513.
106. De Stefani E, Fierro L, Correa P, Fontham E, Ronco A, Larrinaga M, et al. Mate drinking and risk of lung cancer in males: A case-control study from uruguay. Cancer Epidemiol Biomarkers Prev. 1996; 5: 515-519.
107. Pintos J, Franco EL, Oliveira BV, Kowalski LP, Curado MP, Dewar R. Mate, coffee, and tea consumption and risk of cancers of the upper aerodigestive tract in southern brazil. Epidemiology. 1994; 5: 583-590.
108. Goldenberg D, Golz A, Joachims HZ. The beverage mate: A risk fac-tor for cancer of the head and neck. Head Neck. 2003; 25: 595-601.
109. De Stefani E, Fierro L, Mendilaharsu M, Ronco A, Larrinaga MT, Balbi JC, et al. Meat intake, 'mate' drinking and renal cell cancer in uruguay: A case-control study. Br J Cancer. 1998; 78: 1239-1243.
110. De Stefani E, Boffetta P, Deneo-Pellegrini H, Correa P, Ronco AL, Brennan P, et al. Non-alcoholic beverages and risk of bladder cancer in uruguay. BMC Cancer. 2007; 7: 57.
111. Bates MN, Hopenhayn C, Rey OA, Moore LE. Bladder cancer and mate consumption in argentina: A case-control study. Cancer Lett. 2007; 246: 268-273.
112. Kamangar F, Schantz MM, Abnet CC, Fagundes RB, Dawsey SM. High levels of carcinogenic polycyclic aromatic hydrocarbons in mate drinks. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1262-1268.
113. Lioy PJ, Greenberg A. Factors associated with human exposures to polycyclic aromatic hydrocarbons. Toxicol Ind Health. 1990; 6: 209-223.
114. Pufulete M, Battershill J, Boobis A, Fielder R. Approaches to carci-nogenic risk assessment for polycyclic aromatic hydrocarbons: A uk perspective. Regul Toxicol Pharmacol. 2004; 40: 54-66.
115. Qiu L, Leng S, Wang Z, Dai Y, Zheng Y, Wang Z. Path analysis of biomarkers of exposure and early biological effects among coke-oven workers exposed to polycyclic aromatic hydrocarbons. Cancer Epide-miol Biomarkers Prev. 2007; 16: 1193-1199.
116. Vineis P, Talaska G, Malaveille C, Bartsch H, Martone T, Sithisarankul P, et al. DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer. 1996; 65: 314-316.
117. Van Rooij JG, Veeger MM, Bodelier-Bade MM, Scheepers PT, Jon-geneelen FJ. Smoking and dietary intake of polycyclic aromatic hy-drocarbons as sources of interindividual variability in the baseline ex-cretion of 1-hydroxypyrene in urine. Int Arch Occup Environ Health. 1994; 66: 55-65.
118. Lee KH, Vermeulen R, Lenters V, Cho SH, Strickland PT, Kang D. Determinants of urinary 1-hydroxypyrene glucuronide in south ko-rean children. Int Arch Occup Environ Health. 2009; 82: 961-968.
119. Dowlatshahi K, Miller RJ. Role of opium in esophageal cancer: A hy-pothesis. Cancer Res. 1985; 45: 1906-1907.
120. Taioli E, Sram RJ, Garte S, Kalina I, Popov TA, Farmer PB. Effects of polycyclic aromatic hydrocarbons (pahs) in environmental pollution on exogenous and oxidative DNA damage (expah project): Descrip-tion of the population under study. Mutat Res. 2007; 620: 1-6.
121. Kuo CY, Chang SH, Chien YC, Chiang FY, Wei YC. Exposure to car-cinogenic pahs for the vendors of broiled food. J Expo Sci Environ Epidemiol. 2006; 16: 410-416.
122. Lee J, Kang D, Lee KH, Ichiba M, Zhang J, Tomokuni K, et al. Influ-ence of gstm1 genotype on association between aromatic DNA ad-ducts and urinary pah metabolites in incineration workers. Mutat Res. 2002; 514: 213-221.
123. Yilmazer M, Ada AO, Suzen S, Demiroglu C, Demirbag AE, Efe S, et al. Biological monitoring of environmental exposure to polycyclic ar-omatic hydrocarbons: 1-hydroxypyrene in urine of turkish coke oven workers. Bull Environ Contam Toxicol. 2006; 76: 559-565.
124. Unwin J, Cocker J, Scobbie E, Chambers H. An assessment of occu-pational exposure to polycyclic aromatic hydrocarbons in the uk. Ann Occup Hyg. 2006; 50: 395-403.
125. Peabody JW, Riddell TJ, Smith KR, Liu Y, Zhao Y, Gong J, et al. Indoor air pollution in rural china: Cooking fuels, stoves, and health status. Arch Environ Occup Health. 2005; 60: 86-95.
126. Finkelman RB, Belkin HE, Zheng B. Health impacts of domestic coal use in china. Proc Natl Acad Sci U S A. 1999; 96: 3427-3431.
127. Mumford JL, He XZ, Chapman RS, Cao SR, Harris DB, Li XM, et al. Lung cancer and indoorair pollution in xuan wei, china. Science. 1987; 235: 217-220.
128. Wornat MJ, Ledesma EB, Sandrowitz AK, Roth MJ, Dawsey SM, Qiao YL, et al. Polycyclic aromatic hydrocarbons identified in soot extracts from domestic coal-burning stoves of henan province, china. Environ Sci Technol. 2001; 35: 1943-1952.
129. Gevao B, Al-Bahloul M, Zafar J, Al-Matrouk K, Helaleh M. Poly-cyclic aromatic hydrocarbons in indoor air and dust in kuwait: Im-plications for sources and nondietary human exposure. Arch Environ Contam Toxicol. 2007; 53: 503-512.
130. Levy JI, Houseman EA, Spengler JD, Loh P, Ryan L. Fine particulate matter and polycyclic aromatic hydrocarbon concentration patterns in roxbury, massachusetts: A community-based gis analysis. Environ Health Perspect. 2001; 109: 341-347.
131. Marr LC, Grogan LA, Wohrnschimmel H, Molina LT, Molina MJ, Smith TJ, et al. Vehicle traffic as a source of particulate polycyclic aromatic hydrocarbon exposure in the mexico city metropolitan area. Environ Sci Technol. 2004; 38: 2584-2592.
132. Cao SP, Ni HG, Qin PH, Zeng H. Occurrence and human non-dietary exposure of polycyclic aromatic hydrocarbons in soils from shenzhen, china. J Environ Monit. 2010; 12: 1445-1450.
133. Bouchard M, Normandin L, Gagnon F, Viau C, Dumas P, Gaudreau E, et al. Repeated measures of validated and novel biomarkers of expo-sure to polycyclic aromatic hydrocarbons in individuals living near an aluminum plant in quebec, canada. J Toxicol Environ Health A. 2009; 72: 1534-1549.
134. Weinstein JE, Crawford KD, Garner TR, Flemming AJ. Screening-level ecological and human health risk assessment of polycyclic aromatic hydrocarbons in stormwater detention pond sediments of coastal south carolina, USA. J Hazard Mater. 2010; 178: 906-916.
135. Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, et al. Association between gstm1*0 and squamous dysplasia of the esophagus in the high risk region of linxian, china. Cancer Lett. 2000; 156: 73-81.
136. Roth MJ, Wei WQ, Baer J, Abnet CC, Wang GQ, Sternberg LR, et al. Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2391-2396.
137. Abnet CC, Fagundes RB, Strickland PT, Kamangar F, Roth MJ, Tay-lor PR, et al. The influence of genetic polymorphisms in ahr, cyplal, cyp1a2, cyp1b1, gst m1, gst t1 and ugt1a1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from rio grande do sul, brazil. Carcinogenesis. 2007; 28: 112-117.
138. Li Z, SjDin A, Romanoff LC, Horton K, Fitzgerald CL, Eppler A, et al. Evaluation of exposure reduction to indoor air pollution in stove in-tervention projects in peru by urinary biomonitoring of polycyclic aro-matic hydrocarbon metabolites. Environ Int. 2011; 37: 1157-1163.
139. Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, Ar-amesh B. Oesophageal cancer studies in the caspian littoral of iran: Results of a case-control study. Br J Cancer. 1979; 39: 293-309.
140. Hormozdiari H, Day NE, Aramesh B, Mahboubi E. Dietary factors and esophageal cancer in the caspian littoral of iran. Cancer Res. 1975; 35: 3493-3498.
141. Joint Iran-Iarc Study Group. Esophageal cancer studies in the caspian littoral of iran: Results of population studies: A prodrome. J Natl Can-cer Inst. 1977; 54: 1127-1138.